Nope. I posted exactly what they sent. To be fair, this is what my letter was about. Here is what they posted in their initial reply to me. You might find this of interest:
"ViaDerma Investor Relations <info@viadermalicensing.com>
Fri, Sep 7, 11:55 AM (5 days ago)
to me
Jim
Thank you for your email. First, I must admit I was surprised by a comment you made, "You and your investor relations, when they do reply,." We do make sure and respond to every single email, though its certainly possible for an occasional email to slip through the cracks given the amount of correspondence we receive on a daily basis. I checked to see if that was the case with any previous emails from you and found, we had only received email from you a year ago back in September, 2017, and it was replied to promptly.
I really do understand and share in your frustration. I wish I had something different to tell you but at this time I just do not. Every potential deal announced is 100% TRUE AND FACTUAL. Unfortunately we have hit some snags that have delayed our progress. Nonetheless, we are still on track to get all or most of these pending deals completed. We are expecting to have something very significant closed very soon at which time we will announce right away. In the meantime, Amazon sales are increasing, as is the popularity of our product.
We have a world class product that works incredibly well. While getting widespread sales off the ground has proven to be challenging, we believe wholeheartedly that we are very close. In the end, the strength of our flagship product will carry us across the goal line.
Make no mistake, while we have not yet achieved our sale goals, we are working tirelessly to deliver for our shareholders, and we will not stop until we achieve our objectives. We run our business honestly and compliantly. There is no "bilking,"or anything else nefarious going on, only frustration on our part that things have taken longer to materialize than originally anticipated. No one wants to see our sales take off more than we do. Thanks for reaching out and feel free to contact us anytime.
---
ViaDerma Investor Relations
310-734-6111"
